The Prescription Medicines Code of Practice Authority (PMCPA) has called out four pharmaceutical firms for violating the UK industry’s code of practice.
Set up by the country’s leading trade body, the Association of the British Pharmaceutical Industry (ABPI), the PMCPA enforces the so-called ABPI Code, the industry’s self-governance rulebook covering the promotion of prescription medicines.
The PMCPA says that Martindale Pharma, Pierre Fabre, Johnson & Johnson subsidiary Janssen and Pharmasure have breached the code and have “brought discredit upon, and reduced confidence in, the pharmaceutical industry.”
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze